End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,265 KRW | +0.89% | -0.88% | -20.25% |
Business Summary
Number of employees: 75
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
68.3
%
| 32,840 | 67.4 % | 27,454 | 68.3 % | -16.40% |
Fabric
31.7
%
| 15,878 | 32.6 % | 12,749 | 31.7 % | -19.71% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Overseas
89.7
%
| 44,180 | 90.7 % | 36,077 | 89.7 % | -18.34% |
South Korea
10.3
%
| 4,538 | 9.3 % | 4,126 | 10.3 % | -9.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Young-Geun Park
CEO | Chief Executive Officer | 60 | - |
Won-Il Kim
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Byung-Moon Cho
BRD | Director/Board Member | 64 | - |
Jae-Kyung Chae
PRN | Corporate Officer/Principal | 55 | - |
Seong-Ho Choi
AUD | Comptroller/Controller/Auditor | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Byung-Moon Cho
BRD | Director/Board Member | 64 | - |
Young-Geun Park
CEO | Chief Executive Officer | 60 | - |
Sang-Don Kim
BRD | Director/Board Member | 58 | 20-03-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 80,039,035 | 71,452,301 ( 89.27 %) | 209,464 ( 0.2617 %) | 89.27 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
209,464 | 0.26% | 372,825 $ |
Company contact information
GeneOne Life Science, Inc.
20th Floor, Park1 NH Financial Tower 108 Yeoui-daero
07335, Seoul
+
http://www.genels.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-20.25% | 131M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.18% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- A011000 Stock
- Company GeneOne Life Science, Inc.